Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyâ
2026-03-13RVMD144Wang Xiaolin plan to sell securities of Revolution Medicines, Inc. under Form 144MEDIUM
Wang Xiaolin filed Form 144 to notify SEC of plan to sell 2282 units of Revolution Medicines, Inc. securities around 2026-03-16, with aggregate market value of $227,264.38. The total outstanding units is 198173397.0. The amount planned to be sold represents 0.00% of total outstanding units; ...
Large CapBiotechnology
2026-03-13RVMD144Wei Lin plan to sell securities of Revolution Medicines, Inc. under Form 144MEDIUM
Wei Lin filed Form 144 to notify SEC of plan to sell 2288 units of Revolution Medicines, Inc. securities around 2026-03-16, with aggregate market value of $227,861.92. The total outstanding units is 198173397.0. The amount planned to be sold represents 0.00% of total outstanding units; ...
Large CapBiotechnology
2026-03-13CNTA144Weinhoff Gregory M plan to sell securities of Centessa Pharmaceuticals plc under Form 144MEDIUM
Weinhoff Gregory M filed Form 144 to notify SEC of plan to sell 73196 units of Centessa Pharmaceuticals plc securities around 2026-03-13, with aggregate market value of $1,993,493.06. The total outstanding units is 134447836.0. The amount planned to be sold represents 0.05% of total outstanding units; ...
Mid CapBiotechnology
2026-03-13NKTR144Wilson Mark Andrew plan to sell securities of NEKTAR THERAPEUTICS under Form 144MEDIUM
Wilson Mark Andrew filed Form 144 to notify SEC of plan to sell 78510 units of NEKTAR THERAPEUTICS securities around 2026-03-13, with aggregate market value of $5,702,966.40. The total outstanding units is 28687963.0. The amount planned to be sold represents 0.27% of total outstanding units; ...
Small CapBiotechnology
2026-03-13EQ144Zedelmayer Christine plan to sell securities of Equillium, Inc. under Form 144MEDIUM
Zedelmayer Christine filed Form 144 to notify SEC of plan to sell 120312 units of Equillium, Inc. securities around 2026-03-13, with aggregate market value of $288,748.00. The total outstanding units is 60893283.0. The amount planned to be sold represents 0.20% of total outstanding units; Recent transactions in past 3 ...
Micro CapBiotechnology